V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010603 | 250007810 | 1.78 | 70.8 | Disease modification (D) | 2019-02-11 | 2019-02-26 | Azacitidine | 02 | N | 250031118 | AZACITIDINE |
| 250010604 | 250007811 | 1.67 | 67 | Curative (C) | 2014-10-09 | 2014-10-09 | AML 18 TRIAL | N | N | 250031125 | BUSULPHAN |
| 250010605 | 250007812 | 1.7 | null | Curative (C) | 2018-01-02 | 2018-01-25 | CHOP R - 21 days | null | N | 250031129 | RITUXIMAB |
| 250010606 | 250007812 | null | null | null | 2017-01-13 | 2017-01-25 | GEMCARBO | 99 | N | 250031129 | FBC |
| 250010607 | 250007812 | 178 | 113.3 | Palliative (P) | 2013-11-15 | 2013-12-03 | CHOP R - 21 days | N | N | 250031129 | BUSULPHAN |
| 250010608 | 250007813 | 0 | 130 | Disease modification (D) | 2014-09-26 | 2015-02-27 | Rituximab | N | N | 250031159 | PONATINIB |
| 250010609 | 250007814 | 1.83 | 58.6 | Curative (C) | 2015-12-07 | 2015-12-07 | IMATINIB | N | N | 250031175 | ALL MAINTENANCE |
| 250010610 | 250007815 | 1.62 | 60.7 | null | 2017-07-28 | 2017-07-28 | Nilotinib | 02 | N | 250031177 | IGEV R |
| 250010611 | 250007816 | null | 89.3 | Disease modification (D) | 2014-02-19 | 2014-02-19 | IMATINIB | 02 | N | 250031196 | RITUXIMAB |
| 250010612 | 250007817 | null | null | Adjuvant (A) | 2015-12-24 | 2016-11-30 | IMATINIB | 02 | N | 250031198 | BUSULPHAN |
| 250010613 | 250007817 | 1.64 | null | Disease modification (D) | 2015-08-06 | 2015-08-07 | Rituximab | N | N | 250031198 | DA |
| 250010614 | 250007819 | null | 0 | null | 2015-03-28 | 2015-05-09 | PEMBROLIZUMAB | N | null | 250031210 | MELPHALAN |
| 250010615 | 250007820 | 1.7 | 65.5 | Palliative (P) | 2016-08-15 | 2016-08-15 | IPM | 2 | N | 250031216 | AML17 TRIAL |
| 250010616 | 250007820 | 1.71 | 44 | Palliative (P) | 2017-09-28 | 2017-12-23 | GemCarbo Days 1+8 | null | null | 250031216 | VEPEMB |
| 250010617 | 250007821 | null | null | Curative (C) | 2015-11-09 | 2015-11-09 | IMATINIB | null | null | 250031244 | PEG INTERFERON |
| 250010618 | 250007822 | null | 67 | Palliative (P) | 2017-04-14 | 2017-04-14 | IPM | N | N | 250031247 | THALIDOMIDE |
| 250010619 | 250007824 | 1.69 | 61.6 | Palliative (P) | 2016-12-08 | 2016-12-08 | Docetaxel | 2 | N | 250031247 | CYTARABINE |
| 250010620 | 250007825 | 1.78 | 77.3 | Palliative (P) | 2017-09-19 | 2017-09-19 | GEMCARBO | 01 | Y | 250031257 | FLAG + IDARUBICIN |
| 250010621 | 250010914 | 1.66 | 70.8 | Palliative (P) | 2018-01-03 | 2018-01-23 | Bortezomib + Cyclophos + Dex | 02 | N | 250031258 | DASATINIB |
| 250010622 | 250010914 | 0 | 15.7 | Palliative (P) | 2014-09-17 | 2014-09-17 | Trastuzumab 21 day maintenance | 2 | N | 250031258 | CHOP R |
| 250010623 | 250012796 | 1.53 | 76.8 | Palliative (P) | 2015-01-04 | 2015-04-27 | Rituximab (Maintenance) | N | null | 250031268 | VEPEMB |
| 250010624 | 250007827 | null | 0 | Palliative (P) | 2013-02-08 | 2013-02-15 | ABVD | 2 | N | 250031269 | DASATINIB |
| 250010625 | 250007833 | null | null | Palliative (P) | 2015-03-02 | 2015-03-02 | IMATINIB | N | N | 250031279 | CHOP R |
| 250010626 | 250007835 | 1.68 | 73.9 | Palliative (P) | null | 2013-10-29 | ICE-R (Cycle 2 onwards) | N | N | 250031288 | IGEV R |
| 250010628 | 250007838 | null | null | Palliative (P) | null | 2015-12-04 | Busulfan Oral | Y | null | 250031299 | CHOP R |
| 250010629 | 250010918 | 0 | 91.2 | Palliative (P) | 2016-06-22 | 2016-08-08 | ANAGRELIDE | 2 | N | 250031300 | BUSULPHAN |
| 250010630 | 250007841 | null | 75.4 | Disease modification (D) | 2016-01-07 | 2016-01-12 | BUSULFAN | null | N | 250031308 | NOT MATCHED |
| 250010631 | 250007842 | null | 88.6 | Palliative (P) | 2016-12-09 | 2017-02-05 | ANAGRELIDE | N | N | 250031309 | DACTINOMYCIN |
| 250010632 | 250007842 | null | 67.8 | Not known (9) | 2018-11-10 | 2018-11-10 | GemCarbo Days 1+8 | N | null | 250031309 | DASATINIB |
| 250010633 | 250007843 | 1.77 | 74 | Palliative (P) | 2017-05-29 | 2017-05-30 | BENDAMUSTINE + RITUXIMAB | N | N | 250031323 | DASATINIB |
| 250010634 | 250007846 | 1.75 | 20.4 | Palliative (P) | 2017-07-18 | 2017-07-18 | GEMCARBO | null | null | 250031325 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE |
| 250010635 | 250007847 | null | 77.1 | Palliative (P) | 2013-12-29 | 2014-01-05 | Gemcitabine + Capecitabine | 02 | null | 250031327 | GEMCARBO |
| 250010636 | 250007849 | 1.74 | 77 | Palliative (P) | 2013-12-12 | 2014-01-23 | GemCarbo Days 1+8 | N | N | 250031332 | CYTARABINE |
| 250010637 | 250007849 | 1.73 | 66 | Palliative (P) | 2015-10-20 | 2015-10-30 | BUSULFAN + FLUDARABINE | 02 | N | 250031332 | EVEROLIMUS |
| 250010638 | 250007849 | 1.53 | 75.4 | Palliative (P) | 2018-01-19 | 2018-01-29 | Methotrexate intrathecal | 02 | N | 250031332 | FBC |
| 250010639 | 250007850 | null | null | Palliative (P) | 2017-06-29 | 2017-07-07 | THALIDOMIDE | N | N | 250031365 | NILOTINIB |
| 250010640 | 250007850 | 1.64 | 65.05 | null | 2016-01-19 | 2016-01-20 | BUSULFAN | N | null | 250031365 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 250010641 | 250007851 | 1.52 | 0 | Palliative (P) | 2017-01-02 | 2017-01-02 | Rituximab | N | N | 250031377 | ANAGRELIDE |
| 250010642 | 250007852 | null | 45.5 | Palliative (P) | 2018-06-26 | 2018-08-09 | IPM | N | null | 250031381 | GDP |
| 250010643 | 250007853 | 1.48 | null | Palliative (P) | 2015-10-13 | 2015-10-20 | COMMAND trial | 2 | N | 250031394 | NAB-PACLITAXEL |
| 250010644 | 250007854 | 1.74 | 100.65 | Palliative (P) | 2013-05-31 | 2013-06-07 | ANAGRELIDE | null | N | 250031398 | IMATINIB |
| 250010645 | 250007855 | null | null | Palliative (P) | 2015-05-09 | 2015-05-10 | BENDAMUSTINE + RITUXIMAB | 02 | N | 250031403 | CVD |
| 250010646 | 250007856 | 1.68 | 88.8 | Palliative (P) | 2017-12-01 | 2017-12-02 | Carboplatin AUC 6 - 10 | 02 | N | 250031413 | CARBOPLATIN |
| 250010647 | 250010923 | 1.62 | null | null | 2017-06-04 | 2017-06-04 | ANAGRELIDE | N | N | 250031416 | PEMETREXED |
| 250010648 | 250010924 | null | 101.5 | Adjuvant (A) | 2017-10-15 | 2017-10-20 | IPM | 02 | N | 250031419 | CARBOPLATIN + ETOPOSIDE |
| 250010649 | 250010925 | null | null | Palliative (P) | 2015-08-13 | 2015-08-13 | VEPEMB | N | N | 250031419 | GEMCARBO |
| 250010650 | 250007860 | null | null | Palliative (P) | 2016-12-12 | 2016-12-12 | Pemetrexed | N | N | 250031434 | IPM |
| 250010651 | 250007861 | 1.8 | 54.8 | Not known (9) | 2016-08-27 | 2016-08-27 | Cytarabine High Dose | 02 | N | 250031451 | LENALIDOMIDE |
| 250010652 | 250010926 | 0 | 92.1 | Palliative (P) | 2013-10-10 | 2013-10-17 | GemCarbo Days 1+8 | 2 | N | 250031451 | CARBOPLATIN + VINORELBINE |
| 250010653 | 250007862 | null | null | null | 2015-03-29 | 2015-04-12 | COMMAND trial | 2 | null | 250031485 | CHOP R |